These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 20413856)

  • 1. Cardiac output as a potential risk factor for abnormal brain aging.
    Jefferson AL
    J Alzheimers Dis; 2010; 20(3):813-21. PubMed ID: 20413856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac index is associated with brain aging: the Framingham Heart Study.
    Jefferson AL; Himali JJ; Beiser AS; Au R; Massaro JM; Seshadri S; Gona P; Salton CJ; DeCarli C; O'Donnell CJ; Benjamin EJ; Wolf PA; Manning WJ
    Circulation; 2010 Aug; 122(7):690-7. PubMed ID: 20679552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disordered APP metabolism and neurovasculature in trauma and aging: Combined risks for chronic neurodegenerative disorders.
    Ikonomovic MD; Mi Z; Abrahamson EE
    Ageing Res Rev; 2017 Mar; 34():51-63. PubMed ID: 27829172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic risk for Alzheimer's disease alters the five-year trajectory of semantic memory activation in cognitively intact elders.
    Rao SM; Bonner-Jackson A; Nielson KA; Seidenberg M; Smith JC; Woodard JL; Durgerian S
    Neuroimage; 2015 May; 111():136-46. PubMed ID: 25687593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The nature and effects of cortical microvascular pathology in aging and Alzheimer's disease.
    Bailey TL; Rivara CB; Rocher AB; Hof PR
    Neurol Res; 2004 Jul; 26(5):573-8. PubMed ID: 15265277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-related neuropathology, cognitive decline, and Alzheimer's disease.
    Keller JN
    Ageing Res Rev; 2006 Feb; 5(1):1-13. PubMed ID: 16084778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain Aging and Late-Onset Alzheimer's Disease: A Matter of Increased Amyloid or Reduced Energy?
    Mecocci P; Baroni M; Senin U; Boccardi V
    J Alzheimers Dis; 2018; 64(s1):S397-S404. PubMed ID: 29562513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral hypoperfusion, capillary degeneration, and development of Alzheimer disease.
    de la Torre JC
    Alzheimer Dis Assoc Disord; 2000; 14 Suppl 1():S72-81. PubMed ID: 10850734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissecting the Contribution of Vascular Alterations and Aging to Alzheimer's Disease.
    Janota C; Lemere CA; Brito MA
    Mol Neurobiol; 2016 Aug; 53(6):3793-3811. PubMed ID: 26143259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rates of decline distinguish Alzheimer's disease and mild cognitive impairment relative to normal aging: integrating cognition and brain function.
    Liddell BJ; Paul RH; Arns M; Gordon N; Kukla M; Rowe D; Cooper N; Moyle J; Williams LM
    J Integr Neurosci; 2007 Mar; 6(1):141-74. PubMed ID: 17472227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropathological basis of magnetic resonance images in aging and dementia.
    Jagust WJ; Zheng L; Harvey DJ; Mack WJ; Vinters HV; Weiner MW; Ellis WG; Zarow C; Mungas D; Reed BR; Kramer JH; Schuff N; DeCarli C; Chui HC
    Ann Neurol; 2008 Jan; 63(1):72-80. PubMed ID: 18157909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of vascular endothelial growth factor in neurodegeneration and cognitive decline: exploring interactions with biomarkers of Alzheimer disease.
    Hohman TJ; Bell SP; Jefferson AL;
    JAMA Neurol; 2015 May; 72(5):520-9. PubMed ID: 25751166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain structure and function related to cognitive reserve variables in normal aging, mild cognitive impairment and Alzheimer's disease.
    Solé-Padullés C; Bartrés-Faz D; Junqué C; Vendrell P; Rami L; Clemente IC; Bosch B; Villar A; Bargalló N; Jurado MA; Barrios M; Molinuevo JL
    Neurobiol Aging; 2009 Jul; 30(7):1114-24. PubMed ID: 18053618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease.
    Price JL; McKeel DW; Buckles VD; Roe CM; Xiong C; Grundman M; Hansen LA; Petersen RC; Parisi JE; Dickson DW; Smith CD; Davis DG; Schmitt FA; Markesbery WR; Kaye J; Kurlan R; Hulette C; Kurland BF; Higdon R; Kukull W; Morris JC
    Neurobiol Aging; 2009 Jul; 30(7):1026-36. PubMed ID: 19376612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease.
    Daulatzai MA
    J Neurosci Res; 2017 Apr; 95(4):943-972. PubMed ID: 27350397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural neuroimaging in aging and Alzheimer's disease.
    Vernooij MW; Smits M
    Neuroimaging Clin N Am; 2012 Feb; 22(1):33-55, vii-viii. PubMed ID: 22284732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critically attained threshold of cerebral hypoperfusion: the CATCH hypothesis of Alzheimer's pathogenesis.
    de la Torre JC
    Neurobiol Aging; 2000; 21(2):331-42. PubMed ID: 10867218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrovascular resistance: effects on cognitive decline, cortical atrophy, and progression to dementia.
    Yew B; Nation DA;
    Brain; 2017 Jul; 140(7):1987-2001. PubMed ID: 28575149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular mTOR-dependent mechanisms linking the control of aging to Alzheimer's disease.
    Galvan V; Hart MJ
    Biochim Biophys Acta; 2016 May; 1862(5):992-1007. PubMed ID: 26639036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Joint analysis of structural and perfusion MRI for cognitive assessment and classification of Alzheimer's disease and normal aging.
    Tosun D; Mojabi P; Weiner MW; Schuff N
    Neuroimage; 2010 Aug; 52(1):186-97. PubMed ID: 20406691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.